← Evidence map

ArticleScientific reports2025

Integrated molecular and ADME-toxicity profiling identifies PGV-5 and HGV-5 as potential agents to counteract multidrug-resistant (MDR) cancer.

Ritmaleni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Integrated molecular and ADME-toxicity profiling identifies PGV-5 and HGV-5 as potential agents to counteract multidrug-resistant (MDR) cancer. | OpenQuestion